Neuroprotective copper bis(thiosemicarbazonato) complexes promote neurite elongation

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Bica, Laura ^a   Liddell, Jeffrey R ^a   Donnelly, Paul S ^a,b   Duncan, Clare ^a   Caragounis, Aphrodite ^a   Volitakis, Irene ^c   Paterson, Brett M ^a,b   Cappai, Roberto ^a,b   Grubman, Alexandra ^a   Camakaris, James ^a   Crouch, Peter J ^a,c   White, Anthony R ^a,c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER COMPLEX; DIACETYLBIS(N4 METHYLTHIOSEMICARBAZONATO)COPPER; GLYOXALBIS(N4 METHYLTHIOSEMICARBAZONATO)COPPER; PHOSPHATASE; TACROLIMUS; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL ELONGATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME INHIBITION; NERVE FIBER GROWTH; NERVOUS SYSTEM DEVELOPMENT; NEURITE; NEUROPROTECTION; NONHUMAN;

ANIMALS; CALCINEURIN; COORDINATION COMPLEXES; COPPER; ENZYME INHIBITORS; NEURITES; NEUROPROTECTIVE AGENTS; PC12 CELLS; RATS; TACROLIMUS; THIOSEMICARBAZONES; ZINC;

EID: 84896526305     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0090070     Document Type: Article

References (57)

1. Barnham KJ, Bush AI (2008) Metals in Alzheimer's and Parkinson's diseases. Curr Opin Chem Biol 12: 222-228.
2. Schrag M, Mueller C, Oyoyo U, Smith MA, Kirsch WM (2011) Iron, zinc and copper in the Alzheimer's disease brain: a quantitative meta-analysis. Some insight on the influence of citation bias on scientific opinion. Prog Neurobiol 94: 296-306.
3. Tamano H, Takeda A (2011) Dynamic action of neurometals at the synapse. Metallomics 3: 656-661.
4. Gaier ED, Eipper BA, Mains RE (2012) Copper signaling in the mammalian nervous system: Synaptic effects. J Neurosci Res.
5. Kessler H, Pajonk FG, Supprian T, Falkai P, Multhaup G, et al. (2005) [The role of copper in the pathophysiology of Alzheimer's disease]. Nervenarzt 76: 581-585. (Pubitemid 40768538)
6. Faux NG, Ritchie CW, Gunn A, Rembach A, Tsatsanis A, et al. (2010) PBT2 rapidly improves cognition in Alzheimer's Disease: additional phase II analyses. J Alzheimers Dis 20: 509-516.
7. Lannfelt L, Blennow K, Zetterberg H, Batsman S, Ames D, et al. (2008) Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebocontrolled trial. Lancet Neurol 7: 779-786.
8. White AR, Du T, Laughton KM, Volitakis I, Sharples RA, et al. (2006) Degradation of the Alzheimer disease amyloid beta-peptide by metal-dependent up-regulation of metalloprotease activity. J Biol Chem 281: 17670-17680. (Pubitemid 44035565)
9. Crouch PJ, Savva MS, Hung LW, Donnelly PS, Mot AI, et al. (2011) The Alzheimer's therapeutic PBT2 promotes amyloid-beta degradation and GSK3 phosphorylation via a metal chaperone activity. J Neurochem 119: 220-230.
10. Adlard PA, Cherny RA, Finkelstein DI, Gautier E, Robb E, et al. (2008) Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta. Neuron 59: 43-55. (Pubitemid 351905863)
11. Cherny RA, Atwood CS, Xilinas ME, Gray DN, Jones WD, et al. (2001) Treatment with a copper-zinc chelator markedly and rapidly inhibits betaamyloid accumulation in Alzheimer's disease transgenic mice. Neuron 30: 665-676. (Pubitemid 32607332)
12. Crouch PJ, Hung LW, Adlard PA, Cortes M, Lal V, et al. (2009) Increasing Cu bioavailability inhibits Abeta oligomers and tau phosphorylation. Proc Natl Acad Sci U S A 106: 381-386.
13. Malm TM, Iivonen H, Goldsteins G, Keksa-Goldsteine V, Ahtoniemi T, et al. (2007) Pyrrolidine dithiocarbamate activates Akt and improves spatial learning in APP/PS1 mice without affecting beta-amyloid burden. J Neurosci 27: 3712-3721. (Pubitemid 46557689)
14. Hung LW, Villemagne VL, Cheng L, Sherratt NA, Ayton S, et al. (2012) The hypoxia imaging agent CuII(atsm) is neuroprotective and improves motor and cognitive functions in multiple animal models of Parkinson's disease. J Exp Med 209: 837-854.
15. Soon CP, Donnelly PS, Turner BJ, Hung LW, Crouch PJ, et al. (2011) Diacetylbis(N(4)-methylthiosemicarbazonato) copper(II) (CuII(atsm)) protects against peroxynitrite-induced nitrosative damage and prolongs survival in amyotrophic lateral sclerosis mouse model. J Biol Chem 286: 44035-44044.
16. Parker SJ, Meyerowitz J, James JL, Liddell JR, Nonaka T, et al. (2012) Inhibition of TDP-43 accumulation by bis(thiosemicarbazonato)-copper complexes. PLoS One 7: e42277.
17. Adlard PA, Bica L, White AR, Nurjono M, Filiz G, et al. (2011) Metal ionophore treatment restores dendritic spine density and synaptic protein levels in a mouse model of Alzheimer's disease. PLoS One 6: e17669.
18. Donnelly PS, Caragounis A, Du T, Laughton KM, Volitakis I, et al. (2008) Selective intracellular release of copper and zinc ions from bis(thiosemicarbazonato) complexes reduces levels of Alzheimer disease amyloid-beta peptide. J Biol Chem 283: 4568-4577.
19. Donnelly PS, Liddell JR, Lim S, Paterson BM, Cater MA, et al. (2012) An impaired mitochondrial electron transport chain increases retention of the hypoxia imaging agent diacetylbis(4-methylthiosemicarbazonato)copperII. Proc Natl Acad Sci U S A 109: 47-52.
20. Beraldo H, Boyd L, West D (1997) Copper(II) and nickel(II) complexes of glyoxaldehyde bis{N(3)-substituted thiosemicarbazones}. Transition Metal Chemistry 23: 67-71.
21. Bottomley G, Clark I, Creaser I, Engelhardt L, Geue R, et al. (1994) The Synthesis and Structure of Encapsulating Ligands: Properties of Bicyclic Hexamines. Australian Journal of Chemistry 47: 143-179.
22. Gingras BA, Suprunchuk T, Bayley CH (1962) The preparation of some thiosemicarbazones and their copper complexes: part iii. Canadian Journal of Chemistry 40: 1053-1059.
23. Blower PJ, Castle TC, Cowley AR, Dilworth JR, Donnelly PS, et al. (2003) Structural trends in copper(ii) bis(thiosemicarbazone) radiopharmaceuticals. Dalton Transactions 0: 4416-4425.
24. Price KA, Crouch PJ, Volitakis I, Paterson BM, Lim S, et al. (2011) Mechanisms controlling the cellular accumulation of copper bis(thiosemicarbazonato) complexes. Inorg Chem 50: 9594-9605.
25. Price KA, Crouch PJ, Lim S, Paterson BM, Liddell JR, et al. (2011) Subcellular localization of a fluorescent derivative of CuII(atsm) offers insight into the neuroprotective action of CuII(atsm). Metallomics 3: 1280-1290.
26. Yoshii Y, Furukawa T, Kiyono Y, Watanabe R, Mori T, et al. (2011) Internal radiotherapy with copper-64-diacetyl-bis (N4-methylthiosemicarbazone) reduces CD133+ highly tumorigenic cells and metastatic ability of mouse colon carcinoma. Nucl Med Biol 38: 151-157.
27. Price KA (2012) The challenges of using a copper fluorescent sensor (CS1) to track intracellular distributions of copper in neuronal and glial cells. Chemical Science 3: 2748-2759.
28. Cowley S, Paterson H, Kemp P, Marshall CJ (1994) Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77: 841-852. (Pubitemid 24187682)
29. Pang L, Sawada T, Decker SJ, Saltiel AR (1995) Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J Biol Chem 270: 13585-13588.
30. Morooka T, Nishida E (1998) Requirement of p38 mitogen-activated protein kinase for neuronal differentiation in PC12 cells. J Biol Chem 273: 24285-24288. (Pubitemid 28454911)
31. Bica L, Meyerowitz J, Parker SJ, Caragounis A, Du T, et al. (2011) Cell cycle arrest in cultured neuroblastoma cells exposed to a bis(thiosemicarbazonato) metal complex. Biometals 24: 117-133.
32. Meyerowitz J, Parker SJ, Vella LJ, Ng D, Price KA, et al. (2011) C-Jun Nterminal kinase controls TDP-43 accumulation in stress granules induced by oxidative stress. Mol Neurodegener 6: 57.
33. Waetzig V, Herdegen T (2003) The concerted signaling of ERK1/2 and JNKs is essential for PC12 cell neuritogenesis and converges at the level of target proteins. Mol Cell Neurosci 24: 238-249. (Pubitemid 37194548)
34. Eom DS, Choi WS, Oh YJ (2004) Bcl-2 enhances neurite extension via activation of c-Jun N-terminal kinase. Biochem Biophys Res Commun 314: 377-381. (Pubitemid 38084727)
35. Lyons WE, George EB, Dawson TM, Steiner JP, Snyder SH (1994) Immunosuppressant FK506 promotes neurite outgrowth in cultures of PC12 cells and sensory ganglia. Proc Natl Acad Sci U S A 91: 3191-3195. (Pubitemid 24130201)
36. Rozkalne A, Hyman BT, Spires-Jones TL (2011) Calcineurin inhibition with FK506 ameliorates dendritic spine density deficits in plaque-bearing Alzheimer model mice. Neurobiol Dis 41: 650-654.
37. Liu J, Farmer JD Jr, Lane WS, Friedman J, Weissman I, et al. (1991) Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66: 807-815. (Pubitemid 121001714)
38. Fruman DA, Klee CB, Bierer BE, Burakoff SJ (1992) Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A. Proc Natl Acad Sci U S A 89: 3686-3690.
39. Duncan C, White AR (2012) Copper complexes as therapeutic agents. Metallomics 4: 127-138.
40. Kiddie G, McLean D, Van Ooyen A, Graham B (2005) Biologically plausible models of neurite outgrowth. Prog Brain Res 147: 67-80.
41. Xiao J, Liu Y (2003) Differential roles of ERK and JNK in early and late stages of neuritogenesis: a study in a novel PC12 model system. J Neurochem 86: 1516-1523. (Pubitemid 37174268)
42. Jeon CY, Jin JK, Koh YH, Chun W, Choi IG, et al. (2010) Neurites from PC12 cells are connected to each other by synapse-like structures. Synapse 64: 765-772.
43. Greene LA, Tischler AS (1976) Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci U S A 73: 2424-2428.
44. Low LK, Cheng HJ (2006) Axon pruning: an essential step underlying the developmental plasticity of neuronal connections. Philos Trans R Soc Lond B Biol Sci 361: 1531-1544. (Pubitemid 44450209)
45. Trachtenberg JT, Chen BE, Knott GW, Feng G, Sanes JR, et al. (2002) Longterm in vivo imaging of experience-dependent synaptic plasticity in adult cortex. Nature 420: 788-794. (Pubitemid 36019621)
46. Coleman MP, Perry VH (2002) Axon pathology in neurological disease: a neglected therapeutic target. Trends Neurosci 25: 532-537. (Pubitemid 35246324)
47. Birkaya B, Aletta JM (2005) NGF promotes copper accumulation required for optimum neurite outgrowth and protein methylation. J Neurobiol 63: 49-61. (Pubitemid 40344288)
48. Kaden D, Bush AI, Danzeisen R, Bayer TA, Multhaup G (2011) Disturbed copper bioavailability in Alzheimer's disease. Int J Alzheimers Dis 2011: 345614.
49. El Meskini R, Cline LB, Eipper BA, Ronnett GV (2005) The developmentally regulated expression of Menkes protein ATP7A suggests a role in axon extension and synaptogenesis. Dev Neurosci 27: 333-348. (Pubitemid 41243221)
50. Kandel ER (2001) The molecular biology of memory storage: a dialogue between genes and synapses. Science 294: 1030-1038. (Pubitemid 33041851)
51. Sweatt JD (2001) The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory. J Neurochem 76: 1-10.
52. Sweatt JD (2004) Mitogen-activated protein kinases in synaptic plasticity and memory. Curr Opin Neurobiol 14: 311-317. (Pubitemid 38759861)
53. Thomas GM, Huganir RL (2004) MAPK cascade signalling and synaptic plasticity. Nat Rev Neurosci 5: 173-183. (Pubitemid 38252474)
54. Groth RD, Dunbar RL, Mermelstein PG (2003) Calcineurin regulation of neuronal plasticity. Biochem Biophys Res Commun 311: 1159-1171. (Pubitemid 37393439)
55. Jurado S, Biou V, Malenka RC (2010) A calcineurin/AKAP complex is required for NMDA receptor-dependent long-term depression. Nat Neurosci 13: 1053-1055.
56. Jouvenceau A, Dutar P (2006) A role for the protein phosphatase 2B in altered hippocampal synaptic plasticity in the aged rat. J Physiol Paris 99: 154-161.
57. Hidalgo J, Aschner M, Zatta P, Vasak M (2001) Roles of the metallothionein family of proteins in the central nervous system. Brain Res Bull 55: 133-145. (Pubitemid 32722153)